The prevention of heart failure (HF) is an important public health goal, because HF has high prevalence, morbidity, mortality, and associated cost of care. [1] [2] [3] Early identification and aggressive management of patients at high risk of developing HF have been strongly recommended and may be of particular importance in the elderly patients, who are at highest risk of developing HF. 4, 5 Hypertension is one of the most common precursors of HF, and elevated blood pressure (BP) is an important and modifiable risk factor for its development. 6,7 Ambulatory BP monitoring provides information that cannot be obtained from office BP measurements, such as nighttime and daytime mean values and circadian variability. Several epidemiological and clinical studies have demonstrated that ambulatory BP is a better predictor of adverse cardiovascular outcomes than office BP. 8, 9 Left ventricular (LV) global longitudinal strain (GLS) is an echocardiographic measure of LV systolic function and an indicator of early subclinical cardiac dysfunction, even when LV ejection fraction (LVEF) is in the normal range. Moreover, several studies have reported that GLS is a prognostic indicator for mortality, cardiovascular events, and HF development, independent of LVEF. [10] [11] [12] Recently, Ye et al. reported that higher pulsatile arterial load, and especially proximal arterial stiffness, was associated with impaired GLS, and that BP measures failed to show an independent association with GLS; however, ambulatory BP measures were not tested in that study. 13 
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METHODS

Study population
The study cohort was derived from the Cardiovascular Abnormalities and Brain Lesions (CABL) study, whose participants were drawn from the Northern Manhattan Study (NOMAS). NOMAS is a population-based study designed to evaluate the incidence, risk factors, and clinical outcome of stroke in the population of northern Manhattan. Study design and the methodologies of NOMAS have previously been described in detail. 16 Briefly, subjects were eligible if they (i) had never been diagnosed with a stroke, (ii) were ≥40 years of age, and (iii) resided for at least 3 months in a household with a telephone in northern Manhattan. Beginning in September 2005, NOMAS subjects older than 50 years who voluntarily agreed to undergo a brain magnetic resonance imaging study and more extensive cardiovascular assessments were included in the CABL study, which was designed to investigate the relationship between subclinical cardiovascular disease and subclinical brain disease. Participants in CABL who had a complete dataset of 24-hour ambulatory BP monitoring and speckletracking strain imaging constitute the cohort of the present report. Subjects with LVEF <50% were excluded from the analysis.
The study was approved by the institutional review boards of Columbia University Medical Center and the University of Miami. Written informed consent was obtained from all study participants.
Risk factor assessment
Cardiovascular risk factors were ascertained through direct examination and interview by trained research assistants. Diabetes mellitus was defined by the patient's self-report, current use of insulin or hypoglycemic agents, or a fasting blood glucose ≥126 mg/dl on ≥2 occasions. Hypercholesterolemia was defined as total serum cholesterol >240 mg/dl, a patient's self-report of hypercholesterolemia or the use of lipid-lowering medication. Smoking status was defined as self-reported cigarette smoking at any time in the past or present. Body mass index was calculated as: weight/(height) 2 and expressed in kg/m 2 . Coronary artery disease was defined as a history of myocardial infarction, coronary artery bypass grafting, or percutaneous coronary intervention.
Assessment of office BP and 24-hour ambulatory BP
Office systolic BP (SBP) and diastolic BP (DBP) were measured on the nondominant arm in a sitting position after 5 minutes of rest, using a mercury sphygmomanometer and an appropriate size arm cuff. Two BP measurements obtained after an interval of 5 minutes during the same visit were performed and averaged. Ambulatory BP monitoring was performed with an appropriately sized BP cuff on the nondominant arm, using a BP monitor (SpaceLabs Model 90207; Snoqualmie, WA) previously validated by the British Hypertension Society Protocol 17 and calibrated against a reference mercury sphygmomanometer. The methods of ambulatory BP monitoring have been previously published. 18 Briefly, the participants were asked to follow their usual routine and to note their activities at the time of each BP reading in a diary, as well as their sleep onset and wake-up times. A BP reading was automatically taken and recorded every 15 minutes during waking hours and every 30 minutes during sleeping hours for 24 hours. The mean SBP and DBP were calculated for the 24-hour period and separately for daytime (awake) and nighttime (sleep) periods, defined by subjects' diary reports of actual asleep and awake times. BP variability was defined as the SDs of mean BP, and calculated separately for daytime and nighttime. Night-to-day-ratios (nighttime BP/daytime BP) for SBP and DBP were also calculated. Non-dipping pattern was defined as SBP night-to-day ratio >0.9.
Echocardiographic assessment
Two-dimensional echocardiography. Transthoracic echocardiography was performed by trained registered sonographers, following a standardized protocol with a commercially available system (iE 33; Philips, Andover, MA). Interventricular septum and posterior wall thickness, LV end-diastolic and end-systolic diameters were measured from a parasternal long-axis view according to the recommendations of the American Society of Echocardiography. 19 LVEF was calculated using the biplane modified Simpson's rule. LV mass was calculated using the Devereux formula 20 and indexed by body surface area (LVMI).
Peak velocities of the early phase (E) of the mitral inflow were obtained by pulsed-wave Doppler at the mitral valve leaflet tips from an apical 4-chamber view. LV myocardial velocities by tissue Doppler imaging were obtained at the lateral and septal mitral valve annulus. The peak early diastolic (e′) velocity was measured and the E/e′ ratio was calculated as an index of LV filling pressure.
Speckle-tracking GLS imaging. Speckle-tracking analysis was performed off-line using commercially available software (QLAB Advanced Quantification Software version 8.1, Philips). GLS was calculated from the apical 4-chamber and 2-chamber views as previously described. 12, 21 At least 2 cardiac cycles were recorded at a frame rate ≥45 fps, and were averaged for GLS analysis. Reproducibility of speckle-tracking measurements has been reported previously. 22 
Statistical analysis
Data are presented as mean ± SD for continuous variables and as proportions for categorical variables. Univariable linear regression analysis was used to assess the association of each BP measure with LVMI, E/e′ and GLS. Multivariable linear regression analysis was performed separately for each ambulatory and office BP measure to assess their independent association with the echocardiographic parameters after adjustment for pertinent covariates, which were selected based on their bivariate association with each echocardiographic parameter (the threshold for inclusion in the multivariable models was set at a P value of <0.2). To examine whether ambulatory BP measures are more closely associated with the echocardiographic parameters than office BP, corresponding ambulatory and office BP variables were included in the same regression model. A P value of <0.05 was considered statistically significant. Statistical analyses were performed using SAS software version 9.3 (SAS, Cary, NC).
RESULTS
Study population
Of the 1,004 subjects enrolled in CABL, 835 had ambulatory BP monitoring performed. Of these, 604 had diagnostically adequate speckle-tracking GLS imaging available. Among those, 27 participants with LVEF <50% were excluded. Therefore, the final sample size of the present study consisted of 577 participants. The clinical and demographic characteristics of the study population are shown in Table 1 . Almost 70% of the participants were taking antihypertensive medications. Table 2 shows the association of LVMI, E/e′ and GLS with demographics, risk factors and echocardiographic variables. Impaired (i.e., less negative) GLS was significantly associated with older age, diabetes mellitus, coronary artery disease, greater LV mass index (all P < 0.01), and antihypertensive medication use (P < 0.05).
Association of BP measures with GLS
The association of various BP measurements with echocardiographic parameters (LVMI, E/e′ and GLS) is summarized in Table 3 . In univariate linear regression analyses examining each predictor in separately, all office BP and ambulatory BP measures showed significant association with GLS, except the night-to-day ratios, nighttime DBP variability, and non-dipping pattern. Similarly, LVMI showed a significant association with office and ambulatory BP values, except for office DBP. E/e′ showed a significant association with BP night-to-day ratios and daytime DBP as well as with office and ambulatory SBP and SBP variability. Higher BP, both from office and ambulatory measurements, and greater BP variability were consistently associated with greater LVMI and impaired GLS. Higher night-to-day ratios, non-dipping pattern, and lower daytime DBP were significantly associated with higher E/e′. After adjustment (for age, sex, race/ethnicity, body mass index, diabetes mellitus, coronary artery disease, LV mass index, and antihypertensive medication use), office DBP and ambulatory 24-hour, daytime, and nighttime SBP and DBP remained significantly associated with GLS, whereas office SBP was no longer associated. Greater variability in nighttime SBP and daytime DBP also remained significantly associated with impaired GLS; however, neither variable remained independently associated with GLS when the corresponding average ambulatory BP value (nighttime SBP and daytime DBP) was simultaneously included in the regression model. After adjustment for relevant covariates, both ambulatory SBP and DBP remained significantly associated with LVMI, unlike office SBP and DBP. E/e′ was only associated with ambulatory 24-hour, daytime and nighttime SBP. Night-to-day ratios and non-dipping pattern were no longer associated with E/e′ in the multivariable analysis. Values are shown as mean ± SD or n (%). Abbreviations: LV, left ventricular; EF, ejection fraction; GLS, global longitudinal strain; E, early diastolic mitral inflow velocity; e′, early diastolic mitral annular tissue velocity; BP, blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure.
Relationship of GLS to ambulatory BP and office BP
When ambulatory SBP and office SBP, or ambulatory DBP and office DBP, were entered in the same multivariable model, both ambulatory SBP and DBP remained significantly associated with GLS in any of the 24-hour, daytime, and nighttime periods, whereas office SBP and DBP no longer showed a significant association with GLS (Table 4 ). The significant association of ambulatory SBP and DBP with LVMI remained even after an additional adjustment for each corresponding office BP value (Table 4) . Ambulatory SBP (24-hour, daytime, and nighttime) remained significantly associated with E/e′.
DISCUSSION
In this community-based, predominantly elderly cohort, we demonstrated that (i) office DBP and ambulatory SBP and DBP in any of the 24-hour, daytime, and nighttime periods were significantly associated with GLS independently of cardiovascular risk factors; (ii) ambulatory SBP and DBP, but not office BP, were significantly associated with LVMI, whereas only ambulatory SBP was associated with E/e′ after adjustment for demographics and potential confounders; and (iii) ambulatory BP contributed more to explaining the variance of GLS as well as LVMI and E/e′ than office BP.
Previous studies have reported that ambulatory BP was more closely associated with echocardiographic parameters of LV hypertrophy and LV filling pressure than office BP, a circumstance that is in accordance with our findings. 14, 15, 23 Several clinical studies in selected populations with little concomitant disease previously reported that systolic longitudinal strain derived from two-dimensional speckletracking echocardiography was significantly impaired in hypertensive subjects, as well as in subjects with high-normal BP, compared with normotensive control subjects. [24] [25] [26] However, 1 study reported that significantly impaired GLS was observed only in hypertensive patients with extreme LV hypertrophic remodeling (LV mass >190 g). 27 In the present study, we demonstrate in a larger sample a significant association between higher BP values, except for office SBP, and impaired GLS even after adjustment for possible confounders, including diabetes mellitus, coronary artery disease, and LVMI. Furthermore, we demonstrate for the first time that ambulatory BP values are more closely associated with GLS than office BP measurements. Higher ambulatory BP was significantly associated with impaired GLS after adjustment for pertinent covariates and also for office BP, whereas office BP was no longer associated with GLS after adjustments for covariates. Ambulatory BP monitoring allows multiple BP measurements outside of the hospital, which are free from observer bias and white coat effect, and provides more reproducible information than office BP measurements. 28, 29 In fact, marked discrepancies have been documented between office and ambulatory BP measurements. 30 From our results, ambulatory BP monitoring appears to be of value for the identification of subjects at risk of subclinical LV systolic dysfunction, who are at risk of adverse events. [10] [11] [12] Our findings are consistent with previous studies, in which target organ damage and adverse cardiovascular outcomes were more strongly associated with ambulatory BP than with office BP. 8, 9, 31, 32 Hypertension is a major risk factor for HF, not only because it increases the risk of coronary artery disease, but also because elevated BP directly induces pressure-overload, which leads to LV hypertrophy with associated interstitial and perivascular fibrosis. 33, 34 GLS is mainly a measure of the contraction of the longitudinally oriented myocardial fibers, which are mostly located in the LV subendocardium. In a hypertensive animal model, the elevation of wall stress, accumulation of fibrosis, and myocyte hypertrophy were distributed predominantly in the LV subendocardium, and the impairment of GLS occurred in parallel with fibrosis in the early stage of hypertensive HF. 35 In our study, higher ambulatory BP showed a significant association with impaired GLS that was independent of LV mass. Therefore, we speculate that GLS may be impaired in hypertension not only as a result of LV hypertrophy, but also because of a direct effect of increased LV afterload, and that ambulatory BP measurements may provide more accurate information on LV pressure-overload than office BP. Assessing BP status by ambulatory monitoring rather than office BP may help identify subjects at risk of subclinical LV dysfunction, to whom aggressive treatment could be aimed to decrease the likelihood of progression toward clinical systolic dysfunction.
Our study has several limitations. The cross-sectional design does not allow us to detect causal relationships; prospective investigation would be necessary to assess whether ambulatory BP values can predict the future development of subclinical LV dysfunction. The assessment of relative importance of office and ambulatory BP values in the same model can be substantially sample-dependent due to multicollinearity of ambulatory and office BP. However, the beta estimates we presented can be directly interpreted as the change that occurs when each of the relevant variables is added to the same model. Furthermore, despite being representative of the multiethnic community living in northern Manhattan, our cohort is predominantly elderly and has a high frequency of cardiovascular risk factors; therefore the results of the present study might not be directly applicable to other populations with different demographics and risk factor distribution. Finally, our cohort had a high rate of antihypertensive medication use; although antihypertensive treatment was adjusted for in the multivariable analyses, the results may not be directly applicable to a normotensive cohort.
In conclusion, in our community-based, predominantly elderly cohort, higher ambulatory BP was significantly associated with impaired GLS in subjects with normal LVEF, independently of cardiovascular risk factors. Moreover, the association of ambulatory BP with impaired GLS was stronger than office BP values. Ambulatory BP monitoring might have a role in the risk stratification of hypertensive patients for early LV dysfunction.
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